To support the mental health and wellbeing of pharmacists, the Royal Pharmaceutical Society (RPS) is running its fourth annual Workforce Wellbeing survey, in
partnership with Pharmacist Support.
This year it's focussed on exploring some of the obstacles that prevent workforce wellbeing measures being implemented in practice.
It's vital that workplace supports good mental health and wellbeing and provides the right environment to help prevent the negative effects of working under intense
pressure.
RPS urges: "Please complete the survey as soon as you can. It's anonymous, open to pharmacists in all settings including students and you don't need to be a member
of RPS to take part."
"We'll take the results of the survey to governments across Great Britain, the NHS, and wider stakeholders to advocate for improvements to support the mental health
and wellbeing of pharmacists."
The Royal Pharmaceutical Society (RPS) on Wednesday (14 February) launched consultations on two new pioneer curricula defining the clinical capabilities
expected of entry-level advanced pharmacists practising in critical care and mental health.
The advanced pharmacist critical care curriculum and the advanced pharmacist mental health curriculum are supplementary to the RPS core advanced curriculum.
Interested stakeholders are invited to provide feedback on the content of the curricula, their feasibility in terms of delivery, their relevance to all countries,
and how these may impact different social groups.
Both consultations will be open until Tuesday 12 March, and members and non-members of RPS can submit their comments via the online form or the word document.
Today I'm proud to share with you the statement we submitted to the UK Commission on Pharmacy Professional Leadership in which we set out what professional
leadership means to RPS.
I recognise we haven't always been clear in communicating our ideas to members and our external stakeholders. Through the Commission, and our own Independent
Review of member participation and communications, we are determined to remedy this.
We're committed to lead pharmacy in the best interest of patients and the professions. This means that sometimes we will need to take difficult decisions. We will
do the right thing for the long term, ultimately driving what's best for patient care.
There are some key changes we believe are necessary to fulfil the profession's ambitions.
To achieve a more unified approach to pharmacy leadership, we believe both pharmacists and pharmacy technicians should be represented by RPS within professional
faculties that capitalise on the strengths of each discipline whilst retaining distinct professional voices.
Many of our members work with pharmacy technicians every day and know just how essential they are to their role and to patient care. We feel the same at RPS and it
makes perfect sense to evolve into an organisation where both professions can advance their scope of practice, working in alignment as part of the wider
multi-professional team.
We will develop and implement post-registration curricula and credentialing for all pharmacists and pharmacy technicians working with patients and the public. To
do this we will require formal delegation of authority by the GPhC.
The Royal Pharmaceutical Society (RPS) has published a consultation to review the 'Professional standards for the reporting, learning, sharing, taking action
and review of incidents error reporting' in collaboration with Association of Pharmacy Technicians UK and Pharmacy Forum of Northern Ireland.
The consultation is open from 21 April 2023 until 2 June 2023 and are due to be published in early 2024.
All three professional leadership bodies are calling for contributions from anyone using the standards to ensure they are clear, current, relevant and fit for
purpose.
"The review affects all pharmacists, pharmacy technicians, trainees and members of the pharmacy team working in all sectors across the UK," RPS said.
"The standards may also be of interest to the public, people who use pharmacy and healthcare services, healthcare and professionals working with pharmacy teams.
Members of the Royal Pharmaceutical Society (RPS) highlighted the work of pharmacists in making medicines use and the whole NHS more environmentally
sustainable at the Welsh Senedd this week.
Politicians present were informed that around 25 per cent of the NHS' carbon emissions result from medicines use, and therefore pharmacists' expert skills are
crucial for reducing these emissions.
RPS Wales Director, Elen Jones, was among the RPS staff who attended the event, which was co-hosted with the Association of the British Pharmaceutical Industry.
Commenting on the event, Elen said: "It was great to get so many productive conversations with the politicians to highlight the great work pharmacists are already
doing in the sustainability field and to explain what further steps are required to reduce the negative environmental and ecological impact of medicines."
The Royal Pharmaceutical Society (RPS) on Wednesday announced that it is spearheading a new project, which aims to delve into the root causes of the
growing challenge of medicines shortages across the United Kingdom and provide solutions to mitigate its impact on patients and pharmacy practice.
A newly formed advisory group, chaired by RPS Fellow Dr. Bruce Warner, is set to convene later this month. The group will have experts from primary and secondary
care, patient advocacy groups, the pharmaceutical industry, suppliers, regulatory bodies, governmental representatives, and NHS officials.
The group aims to formulate a robust report to provide expert thought leadership and support for the wider debate on UK policy. Their work will be informed by a
thorough literature review, stakeholder interviews, online RPS member events, and patient stories.
Benjamin Hannan, director of reform and transformation at NHS Fife, has been honoured with the prestigious title of Fellow of the Royal Pharmaceutical Society
(RPS), marking a significant milestone in his career.
Hailing from Falkirk, Hannan is the youngest Scottish Fellow in the society's history, a testament to his exceptional contributions to the field of pharmacy.
The fellowship, a distinction bestowed upon members who have demonstrated remarkable achievements in advancing pharmaceutical knowledge or have shown exceptional
distinction in pharmacy science, practice, profession, or history, is a recognition of Hannan's dedication and expertise in the field.
Expressing his gratitude, Hannan told The Faulkner Herlad, "I am delighted and humbled to have been made a Fellow of the Royal Pharmaceutical Society."
The Royal Pharmaceutical Society (RPS) recently announced a valuable addition to their e-library collection: the Maudsley Deprescribing Guidelines,
authored by renowned experts Mark Horowitz and David Taylor.
Designed to assist pharmacists and clinicians in recognising and appropriately treating withdrawal effects of medications, the guidelines have garnered praise
from industry figures like Peter Pratt, National Speciality Advisor for Mental Health Pharmacy and RPS Fellow.
This initiative responds to the increasing demand for guidance on safely reducing or discontinuing psychiatric medications, providing comprehensive support for
clinicians and patients alike.
Drawing on insights from contributors to The Lancet Psychiatry, the handbook offers step-by-step instructions for tapering antidepressants, benzodiazepines,
gabapentinoids, and z-drugs, along with troubleshooting strategies.
The Royal Pharmaceutical Society (RPS) has appointed Professor Parastou Donyai as chief scientist. She will take up the role in June.
Parastou is a pharmacist with a PhD in pharmacy. She also has a postgraduate diploma in Psychological Research Methods as well as a degree in Psychology.
She is currently a professor of Social & Cognitive Pharmacy at the University of Reading and her research examines the psychology of medication use, discontinuation
and decision-making processes.
Prior to this, Parastou also spent more than five years as a senior lecturer in Pharmacy Practice at Kingston University and St. George's University of London. Her
longstanding research interest includes continuing professional development in pharmacy.
Commenting on her appointment, Parastou said: "It is a real privilege for me to be the Royal Pharmaceutical Society's next chief scientist.
"As a pharmacist, scientist and academic, I look forward to working with the Royal Pharmaceutical Society's members and key stakeholders to uphold the value of
science across the breadth of our profession."
The Royal Pharmaceutical Society (RPS) and Pharmacist Support have announced a formal agreement aimed at enhancing collaboration to better support RPS
members and increase the impact of the charity.
This partnership comes after years of working closely together, and formalising it will allow both organisations to reach a wider audience and focus on supporting
the wellbeing of pharmacy professionals.
The aim of the partnership is to establish a visible link between the professional body and the independent charity to increase awareness about the two
organisations for greater focus on the support within the sector.
Along with this, the key objectives also include identifying fundraising opportunities for Pharmacist Support, and collaborating on specific wellbeing projects.
The Royal Pharmaceutical Society (RPS) has cautioned that measures to protect people against Covid-19 must be stepped up in the wake of discovery of the new variant, B.1.1.529.
It has urged members of the public to practice 'hands, face, space and ventilation' protection measures which have become less used in the last few months.
RPS director of pharmacy Robbie Turner said that though it was too early to conclude about the transmissibility or resistance of the new variant to current vaccines, quick action should be taken to protect the public.
"Each one of us must take the necessary precautions of wearing a mask in higher risk situations, maintaining social distancing wherever possible, ensuring there's appropriate ventilation indoors when meeting others and washing our hands regularly."
Encouraging people to take Covid vaccine, he said, it "is still our best defence against this virus".
Working towards its five-year strategy, the Royal Pharmaceutical Society (RPS) has put some plan in place to change its existing structure at the executive level, which could potentially render some senior positions redundant.
Though the process is in nascent stage, "two roles have been identified at potential risk of redundancy," RPS said in a statement on Thursday (March 3) afternoon, adding: "This is very much at proposal stage and no final decisions or outcomes have been reached."0
It didn't specify which two roles were going to be axed, saying: "We are unable to go into the specifics of the process for individuals due to its confidential nature, but we will of course go through a fair, reasonable and confidential consultation process and are supporting the individuals involved.
"No one should be in any doubt that our commitment to education and the profession's development remains the highest priority for us, and equally support for our members, thought leadership and advocacy are core to what we do as a professional leadership body."
The National Pharmacy Association (NPA) and Royal Pharmaceutical Society (RPS) has been appointed as a core participant in the Covid-19 public inquiry.
The independent public inquiry has been set up to examine the UK's response to and the impact of the Covid-19 pandemic and learn lessons to shape preparations for
future pandemics. It is chaired by Baroness Heather Hallett, a former Court of Appeal judge.
The NPA and RPS will be part of Module 3, which covers the impact of Covid-19 on healthcare systems across the United Kingdom. The preliminary hearing for that
module takes place on Tuesday 28 February.
This will give the association an opportunity to make opening and closing statements, consider evidence provided to the Inquiry and propose questions to be asked by
the Inquiry of witnesses.
NPA chief executive, Mark Lyonette, said: "This is an historic opportunity to place on record the achievements of community pharmacy during the pandemic and to ensure
that the inquiry's recommendations are based in the practical realities faced by health workers such as our members.
Recognising her remarkable contribution in the profession of pharmacy, Christine Gilmour, the Director of Pharmacy at NHS Lanarkshire, has been designated
as a Fellow of the Royal Pharmaceutical Society (RPS).
Christine, who joined NHS Lanarkshire as trust chief pharmacist for University Hospital Hairmyres and Stonehouse in 1994. She has been in her current role as
Director of Pharmacy for 17 years now.
Considered to be one of the highest accolades in the domain of pharmacy, this fellowship recognises the distinction of an RPS member in the pharmacy career.
NHS Lanarkshire executive medical director, Dr Chris Deighan commented: "We are extremely proud of Christine. This is a fantastic achievement and recognises
all the hard work, dedication and expertise Christine has displayed across her career."
Recognising the changing practices in healthcare, the Royal Pharmaceutical Society (RPS) has revised and updated its position on the separation of
prescribing and dispensing or administration of a medicine by the same healthcare professional.
It's previous guidance, published in March 2020, restricted prescribing and dispensing by the same healthcare professional only in exceptional circumstances.
The new guidance, jointly developed with the Royal College of Nursing (RCN), has made prescribing and dispensing of medicines more flexible.
It clarifies that "where there is a risk assessment in place and in the best interests of the patient, the same healthcare professional can be responsible for
the prescribing and dispensing / supply / administration of medicines."
The change in the position statement follows an extensive year-long engagement exercise with medical associations, members, fellows, expert advisory groups,
patient groups and the RPS Country Boards.
Jonathan Burton will receive the 2022 RPS Charter Award for his outstanding work for the Society and the wider profession in promoting the interests of pharmacy.
The award will be presented by the President at a future meeting of Fellows and Members to take place at the Society's Edinburgh office on 22nd March 2023.
Jonathan's main role is as a practising, patient-facing pharmacist within the community in NHS Forth Valley where he uses his advanced practice skills and independent
prescribing qualification to assess and treat acute ENT, dermatology, and respiratory conditions.
He was one of the first community pharmacist prescribers in Scotland and has always been at the forefront of innovation and service development.
Jonathan has demonstrated outstanding commitment and passion for the pharmacy profession throughout his career. He has excelled as a pharmacist in the Right Medicine
Pharmacy group, on local and national committees, in advocacy for the pharmacy profession and as a local and national leader who is highly regarded as an exceptional
role model for the profession.
Catriona Sinclair, a community pharmacist in the Highlands with over thirty years' experience, has been elected vice-chair of the Royal Pharmaceutical Society
(RPS)'s Scottish Pharmacy Board.
As the incoming vice-chair, she will sit on the RPS's assembly which is responsible for setting the strategic direction of the Society.
Audrey Thompson, lead pharmacist for Prescribing in NHS Greater Glasgow and Clyde, with over twenty-five years' experience in primary care, was elected to RPS
Assembly.
The newly formed board has three new faces - Josh Miller, Richard Shearer and Jill Swan. In addition, the Board co-opted Kelsey Drummond to a newly created early
career pharmacist place.
There are also three departing board members: Dr Brian Addison, Kathleen Cowle and John McAnaw.
The pharmacy bodies have welcomed Health Select Committee's inquiry into pharmacy services and are calling the community pharmacies to engage fully.
On Thursday (8 June), MPs launched a new inquiry to examine the 'readiness of pharmacy services'. At the end of the inquiry, the committee will be making
recommendations to the government on what action needs to be taken to ensure the potential of pharmacy is realised. It is currently seeking views and evidence
from anyone who can answer any or some of the questions listed here by Thursday 6 July.
National Pharmacy Association (NPA), Company Chemists' Association (CCA) and Royal Pharmaceutical Society (RPS) have confirmed that they will be submitting the
written evidence.
RPS said it will be submitting written evidence, and if they are called to give oral evidence they'll do so.
Malcolm Harrison, Chief Executive of the CCA commented: "We welcome the Health Committee's much-awaited inquiry into pharmacy. Whilst the recent announcement of
investment into the sector is welcome, this is new money for new activity. The historic underfunding of community pharmacy remains, and Primary Care Networks
(PCNs) continue to directly recruit community pharmacists.
Pharmacists from BAME backgrounds still face higher levels of discrimination, harassment, bullying, and career obstacles compared to their white
counterparts, the Pharmacy Workforce Race Equality Standard (PWRES) report has revealed. Published by NHSE England, this report underscores the persistent
presence of inequality, emphasising the crucial need for all stakeholders in the pharmacy sector to prioritise addressing these issues.
The PWRES report indicates that pharmacy team members of Black ethnic backgrounds are less likely to perceive equal opportunities for career advancement or
promotion within their trust. Additionally, female pharmacy team members from BAME backgrounds report higher incidents of personal discrimination in the
workplace. The report also highlights an overrepresentation of pharmacy technicians from BAME backgrounds in lower-paid roles.
"It is shocking and unacceptable to see that across all indicators the BME staff experience is worse than their white counterparts," said Tase Oputu, Chair
of RPS in England.
Extending its support for the Prescription Charges Coalition (PCC), the Pharmacists' Defence Association (PDA) is asking pharmacists in England to share their
experiences of patients denying prescriptions due to financial issues.
PDA members who have practiced in the country within the last 12 months are asked to complete the Prescription Charges Coalition survey by Sunday 28 January.
The PCC is an alliance of more than 50 organisations campaigning to abolish unfair prescription charges for people with long-term conditions in England.
All members of the coalition, including PDA and Royal Pharmaceutical Society (RPS), understand that if patients do not receive their prescribed medicines due to the
cost, their health may deteriorate, and this can increase costs for the National Health Service (NHS).